Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study

INTRODUCTION: The BNT162b2 mRNA-based vaccine has shown high efficacy in preventing COVID-19 infection but there are limited data on the types and persistence of the humoral and T cell responses to such a vaccine. METHODS: Here, we dissect the vaccine-induced humoral and cellular responses in a coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Mestiri, Sarra, Merhi, Maysaloun, Inchakalody, Varghese P., Taib, Nassiba, Smatti, Maria K., Ahmad, Fareed, Raza, Afsheen, Ali, Fatma H., Hydrose, Shereena, Fernandes, Queenie, Ansari, Abdul W., Sahir, Fairooz, Al-Zaidan, Lobna, Jalis, Munir, Ghoul, Mokhtar, Allahverdi, Niloofar, Al Homsi, Mohammed U., Uddin, Shahab, Jeremijenko, Andrew Martin, Nimir, Mai, Abu-Raddad, Laith J., Abid, Fatma Ben, Zaqout, Ahmed, Alfheid, Sameer R., Saqr, Hassan Mohamed Hassan, Omrani, Ali S., Hssain, Ali Ait, Al Maslamani, Muna, Yassine, Hadi M., Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933868/
https://www.ncbi.nlm.nih.gov/pubmed/36817441
http://dx.doi.org/10.3389/fimmu.2023.1061255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933868/
https://www.ncbi.nlm.nih.gov/pubmed/36817441
http://dx.doi.org/10.3389/fimmu.2023.1061255

Ejemplares similares